Dómine, Manuel
Hospital Universitario Fundación Jiménez Díaz · Instituto de Investigación Sanitaria Fundación Jiménez Díaz
2 papers on CoChatORCID 0000-0002-1128-434X
Most cited papers
- Verified
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial.
Provencio, M., Nadal, E., Insa, A., García-Campelo, M. R., Casal-Rubio, J., Dómine, M., Majem, M., Rodríguez-Abreu, D., Martínez-Martí, A., De Castro Carpeño, J., et al. (2020) · The Lancet Oncology
Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations
Cited by 841
- Verified
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non–Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study
Garassino, M. C., Gadgeel, S., Speranza, G., Felip, E., Esteban, E., Dómine, M., Hochmair, M. J., Powell, S. F., Bischoff, H. G., Peled, N., et al. (2023) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers
Cited by 733
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free